期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
鸡血藤精准煮散饮片与原饮片质量的对比性研究 被引量:4
1
作者 徐文 雷迪 +5 位作者 张靖 徐江 黄志海 丘小惠 julie a.hawkins 陈士林 《世界科学技术-中医药现代化》 CSCD 2017年第1期83-88,共6页
目的:本研究采用化学指纹图谱法及DNA条形码分子鉴定技术对鸡血藤饮片煮散质量体系进行探索研究。方法:应用ITS2序列作为DNA条形码对鸡血藤进行鉴定,对比鸡血藤原饮片及精准煮散饮片的出膏率;收集3个批次鸡血藤饮片,采用HPLC法进行3批... 目的:本研究采用化学指纹图谱法及DNA条形码分子鉴定技术对鸡血藤饮片煮散质量体系进行探索研究。方法:应用ITS2序列作为DNA条形码对鸡血藤进行鉴定,对比鸡血藤原饮片及精准煮散饮片的出膏率;收集3个批次鸡血藤饮片,采用HPLC法进行3批次饮片混合粉碎前后质量均一性、指纹图谱与相似度评价。结果:ITS2序列对鸡血藤药材可实现准确鉴定。鸡血藤煮散饮片出膏率及指标成分表儿茶素含量均略高于原饮片;原饮片批间表儿茶素溶出量有明显差异性RSD为11.0%,混合后制成煮散饮片后差异性明显降低RSD为1.0%。指纹图谱中14个共有峰相对峰面积均有所提高,RSD值明显减少。结论:鸡血藤精准煮散饮片提高原饮片的浸出率,成分溶出率及质量均一性,表明鸡血藤煮散饮片有较好的的临床应用优势。 展开更多
关键词 精准煮散饮片 鸡血藤 均一性 DNA条形码 质量体系
下载PDF
三七精准煮散饮片的研制--质量均一性分析 被引量:9
2
作者 张靖 雷迪 +5 位作者 丘小惠 黄志海 徐文 李西文 julie a.hawkins 陈士林 《中国实验方剂学杂志》 CAS CSCD 北大核心 2017年第11期13-17,共5页
目的:饮片质量均一性是中药临床疗效稳定的基础,利用化学指纹图谱结合DNA分子鉴定技术考察三七精准煮散饮片与市售原饮片质量的均一性。方法:应用第二内转录间隔区(ITS2)序列DNA条形码对三七饮片进行分子鉴定;对比三七市售原饮片及精准... 目的:饮片质量均一性是中药临床疗效稳定的基础,利用化学指纹图谱结合DNA分子鉴定技术考察三七精准煮散饮片与市售原饮片质量的均一性。方法:应用第二内转录间隔区(ITS2)序列DNA条形码对三七饮片进行分子鉴定;对比三七市售原饮片及精准煮散饮片的干膏收率;采用HPLC-DAD检测3批三七饮片混合粉碎前后的质量均一性和指纹图谱相似度。结果:三七煮散饮片出膏率显著高于原饮片出膏率;不同批次原饮片间指标成分三七皂苷R_1,人参皂苷Rg_1及Rb_1溶出量有明显的差异性,RSD分别为13.1%,32.7%及24.5%,混合制成煮散饮片后溶出量差异减小,RSD分别为3.6%,2.6%及3.5%;精准煮散饮片提取液中化学成分溶出量较原饮片高。混合粉碎后指纹图谱相似度提高,标定了共有峰14个,峰面积均有提高。结论:三七精准煮散饮片与市售原饮片基本属性相一致,但煮散饮片的浸出、有效成分溶出及质量均一性均有明显提高,提示煮散饮片可提高临床用药的精准性。 展开更多
关键词 三七 精准煮散饮片 DNA条形码 指纹图谱 三七皂苷类 人参皂苷类
原文传递
Medicinal plants of Chinese Pharmacopoeia and Daodi:Insights fromphylogeny and biogeography 被引量:7
3
作者 Di Lei Jie wu +2 位作者 Christine Leon Lin-fang Huang julie a.hawkins 《Chinese Herbal Medicines》 CAS 2018年第3期269-278,共10页
Objective: The Chinese Pharmacopoeia(2015) includes 584 plant medicines, of which 284 also contain high quality subsets, so called "Daodi" components, where Daodi denotes superior clinical properties compare... Objective: The Chinese Pharmacopoeia(2015) includes 584 plant medicines, of which 284 also contain high quality subsets, so called "Daodi" components, where Daodi denotes superior clinical properties compared to non-Daodi counterparts despite being sourced from the same species. Commercial and clinical drivers of selection for Daodi have been described elsewhere. Our objective is to investigate the overall composition of Daodi to determine in what ways medicines with Daodi as a whole differ from the other plants of the Chinese Pharmacopoeia. A further objective is to characterise the Chinese Pharmacopoeia and Daodi in terms of the plant species including their traits and distribution.Methods: We used trait analysis to identify whether Daodi species were significantly different from the remaining Chinese Pharmacopoeia plant species in any traits. We used biogeographic methods and an existing classification of Daodi into 10 regions to identify spatial patterns amongst the species. Regression and binomial analyses were used to test for over-and under-use of plant families and endemic species.Preferences for lineages were visualized using phylogenetic mapping.Results: We found that Daodi species(species with any Daodi subset) were more likely to be roots that are "hot" or "warm", and less likely to be "oxic", according to traditional Chinese medicine(TCM) concepts. Roots were over-represented in the Bei region, and whole plants over-represented in Guang. Both the Chinese Pharmacopoeia and Daodi indicated preferences for families not common in previously studied ethnopharmacopoeias, and fewer endemic species were represented than expected by chance.Conclusion: Using the phylogenetic and biogeographical methods, we highlighted patterns of plant use,and the biological characters of Daodi medicinal plants. Our study points towards cultural preferences in need of scientific explanation. 展开更多
关键词 BIOGEOGRAPHY Chinese Pharmacopoeia Daodi PHYLOGENY
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部